Within the HSA Partnership, HAI uses its research expertise to build an evidence base on access to SRH commodities in Uganda, Kenya, Tanzania and Zambia. With help from our in-country partners HEPS Uganda, Medicines Transparency Alliance Zambia and Medicines Transparency Alliance Kenya we apply a modified version of our gold-standard methodology to measure the price, availability and affordability of more than 30 SRH commodities, as well as perceived barriers to accessing them. The SRH commodities under study consist of a selection of medicines and devices recommended for use by the World Health Organization and United Nations.

Following extensive training sessions led by HAI, in-country data collectors are visiting private, public and mission healthcare facilities across Uganda, Kenya, Zambia and Tanzania to collect this data. During their visits, data collectors also interview facility representatives to determine what they believe are the key challenges to providing SRH commodities to patients, as well as ways to improve access. In addition, facility representatives are being asked if clients are reluctant to access SRH commodities and, if so, how the taboo can be tackled.

HAI and its in-country teams of data collectors carried out the surveys in 2017 and 2018 and will repeat them annually to monitor improvements to access over time.


Research on Sexual and Reproductive Health Commodities

Year 1 Results

SRHC: Measuring Prices, Availability and Affordability – Kenya

SRHC: Measuring Prices, Availability and Affordability – Uganda

SRHC: Measuring Prices, Availability and Affordability – Zambia

Three-country Comparison (Kenya, Uganda and Zambia)
Year 2 Results

SRHC: Measuring Prices, Availability and Affordability
– Kenya

SRHC: Measuring Prices, Availability and Affordability
– Uganda

SRHC: Measuring Prices, Availability and Affordability
– Zambia

SRHC: Measuring Prices, Availability and Affordability
– Tanzania

Four-country Comparison (Kenya, Uganda, Tanzania and Zambia)